Search

everythinglearnresearchcommunity

for

Search:↓

Dihydrotestosterone (DHT) mainly affects nearby cells, doesn't significantly change prostate hormonal environment or cancer risk, and doesn't play a main role in causing hair loss or acne. More research is needed on its effects on heart health, sexual function, and bone health.

Metformin, a diabetes drug, may also help fight cancer, but more research is needed to understand how.

The document concludes that human astrocytes aid stroke recovery, research confidence affects student career aspirations, collagen affects cancer spread, a microRNA suppresses brain cancer growth, calmodulin regulates water channels, and small magnesium pieces deform differently.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Skin and hair can regenerate after injury due to changes in gene activity, with potential links to how cancer spreads. Future research should focus on how new hair follicles form and the processes that trigger their creation.

Neurotoxins can affect neurotransmitter release and have potential in treating muscle, pain, and cancer conditions, but more research is needed on how they work.

Synthetic antioxidants are effective, cheap, and stable, with some like zinc and cholecalciferol reducing child and cancer deaths, but the safety of additives like BHA, BHT, TBHQ, and PEG needs more research.

Protein Kinase Cε increases skin sensitivity to UV damage and skin cancer risk.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

Overexpressing NSD3 in mice causes breast cancer-like tumors and gland abnormalities.

Plucked hair can effectively monitor drug effects in cancer treatment.

Polyamines help repair DNA breaks and may influence cancer development.

A new topical treatment may prevent hair loss from cancer therapy by adjusting cell death processes in hair follicles.

Overactive signaling in hair follicles can lead to skin cancer.

Certain Dibenzo derivatives may help treat prostate cancer.

Promising cancer treatments were found, but the manufacturer closed.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

High DKK1 levels predict worse survival in head and neck cancer.

Some cannabinoid derivatives may be more effective than current drugs at targeting proteins relevant to prostate cancer treatment.

Using 5-alpha reductase inhibitors may lower the risk of breast cancer in females.

LGR5 is a marker found in hair follicle stem cells in various species and is important for hair growth and skin repair.

Not having enough or having too much of the protein Grainyhead-like 3 leads to various developmental problems.

Trichilemmal carcinoma shares genetic traits with other skin cancers, suggesting similar treatment options.

Trichilemmal carcinoma shares genetic traits with other skin cancers, suggesting similar treatment options.

SLCO genes may predict prostate cancer mortality risk, and lifestyle changes improve health in advanced prostate cancer.

New butyric acid prodrugs show promise for cancer treatment, anemia management, and protecting hair from chemotherapy damage.

Cardamonin may help treat oral cancer by promoting cell death and stopping cancer cell growth.

Dauricine may help treat certain brain cancers by reducing cancer cell growth and promoting cell death.

Certain proteins help nerve cells branch, and other findings relate to cancer, stem cell behavior, and cell division.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.